Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression

Genome Research - Tập 22 Số 7 - Trang 1197-1211 - 2012
Suhaida A. Selamat1, Brian S. I. Chung2, Luc Girard3, Wei Zhang4, Ying Zhang2, Mihaela Campan2, Kimberly D. Siegmund2, Michael N. Koss2, Jeffrey A. Hagen2, Wan L. Lam5, Stephen Lam5, Adi F. Gazdar6, Ite A. Laird–Offringa2
1Department of Surgery, Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089-9176, USA.
2University of Southern California
3Hamon Center Therapeutic Oncology - Minna Lab
4University of Texas Southwestern Medical Center
5, University of British Columbia
6Pathology

Tóm tắt

Lung cancer is the leading cause of cancer death worldwide, and adenocarcinoma is its most common histological subtype. Clinical and molecular evidence indicates that lung adenocarcinoma is a heterogeneous disease, which has important implications for treatment. Here we performed genome-scale DNA methylation profiling using the Illumina Infinium HumanMethylation27 platform on 59 matched lung adenocarcinoma/non-tumor lung pairs, with genome-scale verification on an independent set of tissues. We identified 766 genes showing altered DNA methylation between tumors and non-tumor lung. By integrating DNA methylation and mRNA expression data, we identified 164 hypermethylated genes showing concurrent down-regulation, and 57 hypomethylated genes showing increased expression. Integrated pathways analysis indicates that these genes are involved in cell differentiation, epithelial to mesenchymal transition, RAS and WNT signaling pathways, and cell cycle regulation, among others. Comparison of DNA methylation profiles between lung adenocarcinomas of current and never-smokers showed modest differences, identifying only LGALS4 as significantly hypermethylated and down-regulated in smokers. LGALS4, encoding a galactoside-binding protein involved in cell–cell and cell–matrix interactions, was recently shown to be a tumor suppressor in colorectal cancer. Unsupervised analysis of the DNA methylation data identified two tumor subgroups, one of which showed increased DNA methylation and was significantly associated with KRAS mutation and to a lesser extent, with smoking. Our analysis lays the groundwork for further molecular studies of lung adenocarcinoma by identifying novel epigenetically deregulated genes potentially involved in lung adenocarcinoma development/progression, and by describing an epigenetic subgroup of lung adenocarcinoma associated with characteristic molecular alterations.

Từ khóa


Tài liệu tham khảo

10.1007/s00335-011-9318-6

10.1371/journal.pone.0008002

10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H

10.1158/1078-0432.CCR-10-3346

10.1093/nar/gkp942

2002, Gene-expression profiles predict survival of patients with lung adenocarcinoma, Nat Med, 8, 816, 10.1038/nm733

10.1038/nrc1432

2002, Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers, Cancer Res, 62, 2370

1998, Characterization of MAST9/Hevin, a SPARC-like protein, that is down-regulated in non-small cell lung cancer, Cancer Res, 58, 626

10.1038/ng.969

10.1073/pnas.191502998

10.1016/S0092-8674(00)81265-9

10.1016/j.ajhg.2011.03.003

10.1371/journal.pone.0014524

10.1056/NEJMoa0706550

10.1007/978-1-59745-522-0_23

10.1038/nature10166

10.1074/jbc.M703927200

10.1016/j.biocel.2008.11.001

10.1158/0008-5472.CAN-09-1073

10.1093/hmg/ddm051

10.1007/s10549-010-1261-9

10.1186/1471-2407-10-247

10.1002/ijc.20761

10.1038/nrc1252

10.1093/bioinformatics/btn224

10.1016/S1470-2045(03)01115-X

1999, Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients, Cancer Res, 59, 67

10.1007/s10549-009-0339-8

10.1182/blood-2002-06-1735

10.1186/gb-2004-5-10-r80

2004, Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules, Oncol Rep, 11, 453

10.1038/sj.bjc.6605983

10.1158/0008-5472.CAN-09-1595

10.1093/hmg/ddr356

10.1101/gr.117523.110

10.1053/j.gastro.2010.10.009

10.1371/journal.pone.0010312

10.1038/nprot.2008.211

10.1172/JCI38012

10.1158/0008-5472.CAN-10-1451

10.1158/0008-5472.CAN-08-2807

10.1158/1940-6207.CAPR-10-0039

10.1038/ng.298

10.1038/nrc1507

10.3322/caac.20107

10.1093/carcin/bgn102

10.1038/sj.onc.1205597

10.1101/gr.133645.111

10.1161/ATVBAHA.110.216341

2007, The role of DNA methylation in the development and progression of lung adenocarcinoma, Dis Markers, 23, 5, 10.1155/2007/985474

10.1158/1078-0432.CCR-04-2206

10.1158/0008-5472.CAN-04-4562

10.1038/sj.onc.1207433

10.1002/mc.1053

10.1016/j.lungcan.2008.12.001

10.1371/journal.pone.0013066

10.1371/journal.pone.0001651

10.1158/1078-0432.CCR-06-2525

10.1002/cm.20436

10.1038/nrg2825

10.1002/ijc.20294

10.1371/journal.pone.0000093

10.1038/sj.emboj.7600174

10.1593/neo.05406

10.1093/hmg/ddq351

10.1016/j.ccr.2011.03.018

10.1053/j.gastro.2007.03.003

10.1038/nm.2673

10.1016/j.bbrc.2008.05.101

10.1038/onc.2011.354

10.1158/1055-9965.EPI-10-0332

10.1158/0008-5472.CAN-06-1687

10.1038/nature09165

10.1016/j.canlet.2004.08.040

10.1016/j.ccr.2011.02.005

10.1038/onc.2011.233

10.1016/j.cell.2009.04.030

10.1182/blood-2001-11-0032

2005, Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma, Oncogene, 24, 6406, 10.1038/sj.onc.1208788

10.1158/1078-0432.CCR-10-2320

10.1016/j.ccr.2010.03.017

10.2353/jmoldx.2006.060082

10.1038/ng1972

10.1016/S0959-8049(01)00089-2

10.1038/sj.onc.1205303

10.1002/ijc.25951

10.1016/S1470-2045(10)70087-5

10.1073/pnas.0405220101

10.1371/journal.pmed.0020073

10.1371/journal.pmed.0020017

10.3858/emm.2011.43.2.011

10.1371/journal.pone.0018223

10.1186/1755-8794-2-11

10.1097/PAI.0b013e3182233f9f

2003, Promoter hypermethylation of the O 6 -methylguanine-DNA methyltransferase gene: More common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression, Cancer Res, 63, 4842

10.1159/000087379

R Development Core Team. 2011. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/.

10.1158/0008-5472.CAN-08-1320

10.1073/pnas.0701059104

2005, Identification by means of cDNA microarray analyses of gene expression modifications in squamous non-small cell lung cancers as compared to normal bronchial epithelial tissue, Int J Oncol, 26, 247

10.1002/ijc.23605

10.1186/bcr2121

2011, Cancer epigenetics reaches mainstream oncology, Nat Med, 17, 330, 10.1038/nm.2305

10.1158/1078-0432.CCR-06-1268

10.1210/en.2008-0203

10.1158/1078-0432.CCR-05-0729

10.1136/jcp.2005.031161

10.1158/0008-5472.CAN-10-2342

10.4161/epi.6.6.16216

10.1002/ijc.25750

2003, Epigenetic inactivation of laminin-5-encoding genes in lung cancers, Clin Cancer Res, 9, 2665

10.1007/s004390050790

2003, Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays, Cancer Res, 63, 3735

10.1055/s-0029-1241859

10.1038/ng1950

10.1371/journal.pone.0021443

10.1073/pnas.0704652104

10.1002/ijc.25907

10.1016/j.bbrc.2011.06.121

10.1038/sj.onc.1205453

10.1056/NEJMoa032178

10.1073/pnas.1530509100

10.1038/nrc2190

10.1002/ijc.26164

10.1002/cncr.21853

10.1093/nar/28.14.2627

10.1093/jnci/djj105

10.1371/journal.pone.0019862

10.1016/j.canlet.2008.03.022

10.1513/pats.200805-045TH

10.1200/JCO.2005.04.8033

10.1371/journal.pone.0010594

10.1002/ijc.10787

10.1158/0008-5472.CAN-05-2625

10.1074/jbc.M400661200

10.1073/pnas.96.15.8681

10.1097/JTO.0b013e318206a221

10.1186/1755-8794-2-65

10.1016/j.lungcan.2004.08.003

10.1186/1476-4598-6-70

2002, Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer, Cancer Res, 62, 371

10.1158/0008-5472.CAN-08-2489

10.1158/1078-0432.CCR-10-3394

10.1186/bcr2586

10.1186/1471-2407-7-66

10.1182/blood-2010-04-279539

10.1038/sj.onc.1207232

10.1038/sj.onc.1205953

10.1097/JTO.0b013e3181d6e0b3

2011, Clinical significance of circulating galectins as colorectal cancer markers, Oncol Rep, 25, 1217

10.1038/ng1834

10.1038/sj.onc.1205726

10.1158/1078-0432.CCR-08-2188

10.1158/1078-0432.CCR-09-2006

10.1038/88225

10.1158/1078-0432.CCR-07-0015

10.1158/0008-5472.CAN-07-6349

Thông tin
Thông tin xuất bản

Genome Research

Tập 22 Số 7

1197-1211

Thông tin tác giả